Drug interactions
Empagliflozin-linagliptin + Insulin glulisine
Severity: Moderate
Empagliflozin-linagliptin and Insulin glulisine: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Combining empagliflozin and linagliptin with insulin lowers blood glucose further and raises the risk of hypoglycemia. The risk is highest when insulin doses were titrated before the oral agents were added.
What this interaction means in plain words
Empagliflozin-linagliptin and Insulin glulisine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Empagliflozin-linagliptin belongs to Endocrine; Insulin glulisine belongs to Endocrine.
Why it happens
Additive glucose-lowering effects through insulin-independent glucosuria, enhanced incretin activity and exogenous insulin.
What to do
Monitor blood glucose closely when starting the combination and consider lowering the insulin dose. Educate the patient about hypoglycemia symptoms.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Empagliflozin-linagliptin and Insulin glulisine, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Empagliflozin-linagliptin
Other interactions of Insulin glulisine
Frequently asked questions
Can I take Empagliflozin-linagliptin with Insulin glulisine?
MediHelp rates the interaction as moderate. Empagliflozin-linagliptin and Insulin glulisine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Combining empagliflozin and linagliptin with insulin lowers blood glucose further and raises the risk of hypoglycemia. The risk is highest when insulin doses were titrated before the oral agents were added.
How serious is the interaction between Empagliflozin-linagliptin and Insulin glulisine?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose closely when starting the combination and consider lowering the insulin dose. Educate the patient about hypoglycemia symptoms.
What other medicines interact with Empagliflozin-linagliptin?
MediHelp also lists interactions of Empagliflozin-linagliptin with, for example, Fosphenytoin, Rifampin, Rifapentine. The full list is on the Empagliflozin-linagliptin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
